Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cortexyme Inc
(NQ:
CRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cortexyme Inc
< Previous
1
2
3
4
5
Next >
Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression
October 26, 2021
From
Cortexyme, Inc.
Via
Business Wire
Why This Alzheimer's Study Missed, But That's Not Necessarily A Bad Thing For Cortexyme
October 26, 2021
Cortexyme said Tuesday its experimental Alzheimer's drug might work in some patients.
Via
Investor's Business Daily
Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market
October 21, 2021
Cortexyme is testing a twice-day pill to treat Alzheimer's disease.
Via
Investor's Business Daily
Cramer Likes Azek And SoFi, But Said Owning This Stock Could Be Dreadful
October 08, 2021
On CNBC's "Mad Money Light...
Via
Benzinga
Before The Bubble Bursts
August 14, 2021
Maybe some good can come out of the market bubble -- for Alzheimer's patients, and for investors in Cortexyme.
Via
Talk Markets
Analyzing Cortexyme's Unusual Options Activity
August 09, 2021
On Monday, shares of Cortexyme (NASDAQ:CRTX) saw unusual ...
Via
Benzinga
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
Cortexyme to Present Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer’s Disease at CTAD 2021
September 27, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme Expands Proprietary Development Pipeline with Initiation of Phase 1 Clinical Trial of COR588
September 08, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th
September 07, 2021
From
Cortexyme, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Thursday
August 26, 2021
Keybanc raised the price target for Intuit Inc. (NASDAQ:
Via
Benzinga
Cortexyme Presents New Data Demonstrating Evidence of P. Gingivalis Infection of the Central Nervous System in Alzheimer’s Disease at Annual Biomarkers for Alzheimer’s Disease Summit
August 25, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Annual Biomarkers for Alzheimer’s Disease Summit
August 18, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme: Shifting The Odds In Your Favor So Your Best Case Outcome Is Three Times Higher Than Your Worst Case
August 16, 2021
Screen capture via Cortexyme animation. A Bigger Bubble Than The Late '90s Phoenix Capital Research offered an interesting comparison of the current stock market to that...
Via
Benzinga
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 10, 2021
Gainers CohBar (NASDAQ:CWBR) shares incr...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
85 Biggest Movers From Yesterday
August 11, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 10, 2021
Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (...
Via
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
COVID-19
68 Biggest Movers From Yesterday
August 10, 2021
Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a...
Via
Benzinga
Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher
August 09, 2021
Toward the end of trading Monday, the Dow traded down 0.17% to 35,150.02 while the NASDAQ rose 0.26% to 14,874.23. The S&P also rose, gaining 0.01% to 4,436.62. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
August 09, 2021
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 33.66% to $4.3 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 87.6...
Via
Benzinga
Mid-Day Market Update: Crude Oil Down 2.5%; Golden Nugget Online Gaming Shares Jump
August 09, 2021
Midway through trading Monday, the Dow traded down 0.23% to 35,126.98 while the NASDAQ rose 0.20% to 14,866.01. The S&P also fell, dropping 0.08% to 4,432.96. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Cortexyme Provides Business Update and Reports Second Quarter 2021 Results
August 09, 2021
From
Cortexyme, Inc.
Via
Business Wire
Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th
August 04, 2021
From
Cortexyme, Inc.
Via
Business Wire
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer’s Disease at AAIC 2021
July 26, 2021
From
Cortexyme, Inc.
Via
Business Wire
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.